Want to join the conversation?
Pharmaceutical company $ENDP reported net income of $343.5MM or $1.54 per share in 2Q16 compared to a net loss of $250.5MM or $1.35 per share in 2Q15, helped by higher revenues and tax benefits. Total revenues increased by 25% to $921MM from last year, primarily attributable to revenues related to the Par Pharmaceutical acquisition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?